tiprankstipranks
Trending News
More News >
IAG Holdings Limited (HK:8513)
:8513
Hong Kong Market
Advertisement

IAG Holdings Limited (8513) AI Stock Analysis

Compare
0 Followers

Top Page

HK:8513

IAG Holdings Limited

(8513)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 4o)
Rating:41Neutral
Price Target:
HK$0.00
▼(-100.00% Downside)
The overall stock score is heavily influenced by poor financial performance, characterized by declining revenue, negative profit margins, and high leverage. Technical analysis also indicates bearish trends, while valuation metrics highlight financial distress. These factors collectively suggest significant risks and challenges for the company.

IAG Holdings Limited (8513) vs. iShares MSCI Hong Kong ETF (EWH)

IAG Holdings Limited Business Overview & Revenue Model

Company DescriptionIAG Holdings Limited is an investment holding company mainly engaged in the manufacturing and sale of injection molded plastic parts for disposable medical devices. It also provides tooling services. Molded plastic parts include component parts, as well as assembly of plastic parts assembled into sub-assembly products. The injection molded plastic parts are made for a range of medical uses such as respiratory products, dialysis products, blood bag products, drug delivery products and diagnostic tools. Tooling services are the services provided for the fabrication of mold to be used in the injection molding process. The major consumers include multinational corporation (MNC) medical device companies from the United States, Europe and Japan.
How the Company Makes MoneyIAG Holdings Limited generates revenue primarily through the sale of its LED lighting products and electronic components. The company's revenue streams include direct sales to distributors and retailers, as well as project-based contracts with commercial and industrial clients. Additionally, IAG Holdings Limited may engage in strategic partnerships with other companies in the technology and lighting sectors to enhance its market presence and expand its product offerings. Factors such as advancements in LED technology, increasing demand for energy-efficient lighting solutions, and government initiatives promoting sustainable energy use significantly contribute to the company's earnings.

IAG Holdings Limited Financial Statement Overview

Summary
IAG Holdings Limited faces significant financial challenges with declining revenue, negative profit margins, and high leverage. The company's balance sheet and cash flow statements reveal financial instability and liquidity concerns, necessitating strategic improvements to enhance financial health and operational efficiency.
Income Statement
35
Negative
IAG Holdings Limited shows declining revenue and profit margins. Revenue decreased by 28.5% from 2022 to 2023, with further declines in 2024. Gross profit margin and net profit margin are negative, indicating cost management issues and unprofitability. EBIT and EBITDA margins are also negative, reflecting operational inefficiency and financial stress.
Balance Sheet
40
Negative
The balance sheet shows a high debt-to-equity ratio and declining equity, indicating financial risk and reduced stability. The equity ratio has also decreased, reflecting less asset coverage by equity. These factors suggest potential solvency concerns, though total liabilities have slightly reduced over the period.
Cash Flow
30
Negative
IAG Holdings Limited has negative free cash flow and operating cash flow, indicating poor cash generation from operations and limited flexibility in managing capital expenditures. The lack of positive cash flow indicates potential liquidity challenges, with free cash flow trends showing inconsistency and overall decline.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue12.65M10.46M9.15M13.90M19.77M23.20M
Gross Profit1.71M44.00K-730.00K938.00K3.97M4.56M
EBITDA-258.50K-1.35M-2.40M-1.76M-4.63M4.33M
Net Income-1.24M-2.63M-6.75M-3.06M-7.05M784.00K
Balance Sheet
Total Assets8.34M8.75M10.06M16.32M20.91M32.16M
Cash, Cash Equivalents and Short-Term Investments759.00K1.78M1.60M3.66M5.99M4.38M
Total Debt4.05M4.20M4.24M2.59M3.52M5.11M
Total Liabilities6.42M6.63M7.19M7.19M10.16M14.48M
Stockholders Equity1.94M2.14M2.88M8.65M10.10M17.17M
Cash Flow
Free Cash Flow-1.14M-1.24M-1.25M-1.37M2.92M2.83M
Operating Cash Flow-1.09M-986.00K-1.19M-582.00K3.16M3.09M
Investing Cash Flow64.00K-145.00K3.00K-751.00K-365.00K-163.00K
Financing Cash Flow-210.00K1.31M509.00K-474.00K-3.19M-2.16M

IAG Holdings Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.12
Price Trends
50DMA
0.13
Negative
100DMA
0.13
Negative
200DMA
0.14
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
41.23
Neutral
STOCH
34.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8513, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.12, below the 50-day MA of 0.13, and below the 200-day MA of 0.14, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 41.23 is Neutral, neither overbought nor oversold. The STOCH value of 34.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8513.

IAG Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
HK$82.40M8.738.84%2.43%15.32%20.41%
59
Neutral
HK$184.61M7.61-7.71%-34.73%-5898.70%
55
Neutral
HK$94.85M-10.31%-11.68%-71.01%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
45
Neutral
HK$287.40M-8.46%45.13%
44
Neutral
HK$89.00M-8.72%26.06%13.23%
41
Neutral
HK$98.21M-75.03%47.80%82.95%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8513
IAG Holdings Limited
0.12
-0.09
-42.86%
HK:0876
Kaisa Health Group Holdings Limited
0.06
0.04
146.15%
HK:1134
Kelfred Holdings Limited
0.18
-0.08
-30.77%
HK:2211
Universal Health International Group Holding Ltd.
1.65
0.55
50.00%
HK:8357
Republic Healthcare Limited
0.15
0.07
87.50%
HK:8372
Grand Brilliance Group Holdings Limited
0.10
0.00
0.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 04, 2025